Kelly Michael's most recent trade in DMC Global Inc was a trade of 5,518 Common Stock done . Disclosure was reported to the exchange on Feb. 26, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
DMC Global Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 5,518 | 31,073 (0%) | 0% | 0 | Common Stock | |
Mettler-Toledo Internation... | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2024 | 182 | 182 | - | - | Stock Option (right to buy) | |
Mettler-Toledo Internation... | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2024 | 71 | 120 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
Herc Holdings Inc | Michael A. Kelly | Director | Sale of securities on an exchange or to another person at price $ 208.83 per share. | 24 Oct 2024 | 3,880 | 13,774 (0%) | 0% | 208.8 | 810,260 | Common Stock |
Neogenomics Inc. | Michael A. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2024 | 11,336 | 0 | - | - | Restricted Stock Unit | |
Neogenomics Inc. | Michael A. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2024 | 11,336 | 31,755 (0%) | 0% | 0 | Common Stock | |
ARS Pharmaceuticals Inc | Michael Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
Cars.com | Michael Joseph Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 8,726 | 91,058 (0%) | 0% | 0 | Common Stock | |
Neogenomics Inc. | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 12,254 | 12,254 | - | - | Restricted Stock Unit | |
Neogenomics Inc. | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 8,672 | 8,672 | - | - | Stock Option (Right to Buy) | |
Herc Holdings Inc | Michael A. Kelly | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 May 2024 | 9,399 | 17,654 (0%) | 0% | 0 | Common Stock | |
Herc Holdings Inc | Michael A. Kelly | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 May 2024 | 9,399 | 834 (0%) | 0% | 0 | Common Stock | |
Herc Holdings Inc | Michael A. Kelly | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 May 2024 | 8,255 | 8,255 (0%) | 0% | 0 | Common Stock | |
Herc Holdings Inc | Michael A. Kelly | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 May 2024 | 8,255 | 10,233 (0%) | 0% | 0 | Common Stock | |
Herc Holdings Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 834 | 18,488 (0%) | 0% | 0 | Common Stock | |
DMC Global Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 9,520 | 25,555 (0%) | 0% | 0 | Common Stock | |
Mettler-Toledo Internation... | Kelly A. Michael | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 1,268 | 0 | - | - | Stock Option (right to buy) | |
Mettler-Toledo Internation... | A. Kelly Michael | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 263.62 per share. | 12 Feb 2024 | 1,268 | 2,945 (0%) | 0% | 263.6 | 334,270 | Common Stock, par value $0.01 per share |
Mettler-Toledo Internation... | Michael A. Kelly | Director | Sale of securities on an exchange or to another person at price $ 1175.74 per share. | 12 Feb 2024 | 400 | 2,018 (0%) | 0% | 1175.7 | 470,296 | Common Stock, par value $0.01 per share |
Mettler-Toledo Internation... | Michael Kelly A. | Director | Sale of securities on an exchange or to another person at price $ 1178.16 per share. | 12 Feb 2024 | 341 | 1,677 (0%) | 0% | 1178.2 | 401,753 | Common Stock, par value $0.01 per share |
Mettler-Toledo Internation... | Kelly A. Michael | Director | Sale of securities on an exchange or to another person at price $ 1174.68 per share. | 12 Feb 2024 | 227 | 2,418 (0%) | 0% | 1174.7 | 266,652 | Common Stock, par value $0.01 per share |
Mettler-Toledo Internation... | A. Kelly Michael | Director | Sale of securities on an exchange or to another person at price $ 1170.32 per share. | 12 Feb 2024 | 200 | 2,745 (0%) | 0% | 1170.3 | 234,064 | Common Stock, par value $0.01 per share |
Mettler-Toledo Internation... | A. Kelly Michael | Director | Sale of securities on an exchange or to another person at price $ 1171.31 per share. | 12 Feb 2024 | 100 | 2,645 (0%) | 0% | 1171.3 | 117,131 | Common Stock, par value $0.01 per share |
EchoStar Corp - Ordinary S... | Kelly Michael | ExcVP/Grp Pres,Retail Wireless | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 148,817 | 148,817 | - | - | Employee Stock Option (Option to Buy) | |
EchoStar Corp - Ordinary S... | Michael Kelly | ExcVP/Grp Pres,Retail Wireless | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 53,384 | 53,384 (0%) | 0% | - | Class A Common Stock | |
EchoStar Corp - Ordinary S... | Kelly Michael | ExcVP/Grp Pres,Retail Wireless | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 26,621 | 26,621 | - | - | Employee Stock Option (Option to Buy) | |
Cars.com | Kelly Joseph Michael | Director | Purchase of securities on an exchange or from another person at price $ 9.94 per share. | 13 Dec 2023 | 2,510 | 15,685 (0%) | 0% | 9.9 | 24,949 | Common Stock |
Mettler-Toledo Internation... | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2023 | 250 | 250 | - | - | Stock Option (right to buy) | |
Mettler-Toledo Internation... | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2023 | 49 | 1,677 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
Neogenomics Inc. | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 11,336 | 11,336 | - | - | Restricted Stock Unit | |
Neogenomics Inc. | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 8,353 | 8,353 | - | - | Stock Option (Right to Buy) | |
ARS Pharmaceuticals Inc | Michael Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
Cars.com | Michael Joseph Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 9,371 | 82,322 (0%) | 0% | 0 | Common Stock | |
Herc Holdings Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 1,301 | 17,654 (0%) | 0% | 0 | Common Stock | |
DMC Global Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 7,086 | 16,035 (0%) | 0% | 0 | Common Stock | |
ARS Pharmaceuticals Inc | Michael Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2022 | 118,190 | 118,190 | - | - | Employee Stock Option (Right to Buy) | |
ARS Pharmaceuticals Inc | Michael Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2022 | 83,225 | 83,225 | - | - | Common Stock | |
ARS Pharmaceuticals Inc | Michael Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2022 | 70,422 | 70,422 | - | - | Employee Stock Option (right to buy) | |
Mettler-Toledo Internation... | Michael A. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 244.99 per share. | 08 Nov 2022 | 1,484 | 3,112 (0%) | 0% | 245.0 | 363,565 | Common Stock, par value $0.01 per share |
Mettler-Toledo Internation... | Michael A. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2022 | 1,484 | 0 | - | - | Stock Option (right to buy) | |
Mettler-Toledo Internation... | Michael A. Kelly | Director | Sale of securities on an exchange or to another person at price $ 1357.65 per share. | 08 Nov 2022 | 784 | 1,628 (0%) | 0% | 1357.7 | 1,064,398 | Common Stock, par value $0.01 per share |
Mettler-Toledo Internation... | Michael A. Kelly | Director | Sale of securities on an exchange or to another person at price $ 1354.92 per share. | 08 Nov 2022 | 700 | 2,412 (0%) | 0% | 1354.9 | 948,444 | Common Stock, par value $0.01 per share |
Mettler-Toledo Internation... | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2022 | 224 | 224 | - | - | Stock Option (right to buy) | |
Mettler-Toledo Internation... | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2022 | 41 | 1,628 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
Neogenomics Inc. | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 15,556 | 20,419 (0%) | 0% | 0 | Common Stock | |
Neogenomics Inc. | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 13,882 | 13,882 | - | - | Stock Option (Right to Buy) | |
Cars.com | Michael Joseph Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,342 | 72,951 (0%) | 0% | 0 | Common Stock | |
Herc Holdings Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 1,101 | 16,353 (0%) | 0% | 0 | Common Stock | |
DMC Global Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 5,006 | 8,949 (0%) | 0% | 0 | Common Stock | |
Northern Oil and Gas Inc. | Michael D. Kelly | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 3,503 | 30,042 (0%) | 0% | 0 | Common Stock | |
Northern Oil and Gas Inc. | Michael D. Kelly | Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 28.34 per share. | 01 Apr 2022 | 13,000 | 26,539 (0%) | 0% | 28.3 | 368,364 | Common Stock |
Northern Oil and Gas Inc. | Michael D. Kelly | Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.64 per share. | 15 Mar 2022 | 7,952 | 39,539 (0%) | 0% | 24.6 | 195,937 | Common Stock |
Northern Oil and Gas Inc. | Michael D. Kelly | Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.71 per share. | 01 Jan 2022 | 792 | 47,491 (0%) | 0% | 21.7 | 17,194 | Common Stock |
Northern Oil and Gas Inc. | Michael D. Kelly | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2021 | 11,572 | 48,283 (0%) | 0% | 0 | Common Stock | |
Mettler-Toledo Internation... | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2021 | 222 | 222 | - | - | Stock Option (right to buy) | |
Mettler-Toledo Internation... | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2021 | 30 | 1,587 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
Aprea Therapeutics Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 22,750 | 22,750 | - | - | Stock Option (Right to Buy) | |
Aprea Therapeutics Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 4,610 | 4,610 (0%) | 0% | 0 | Common Stock | |
Cars.com | Michael Joseph Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 12,858 | 55,609 (0%) | 0% | 0 | Common Stock | |
Herc Holdings Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 1,034 | 15,252 (0%) | 0% | 0 | Common Stock | |
DMC Global Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 1,888 | 3,943 (0%) | 0% | 0 | Common Stock | |
Northern Oil and Gas Inc. | Michael D. Kelly | Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.91 per share. | 15 Mar 2021 | 4,216 | 36,711 (0%) | 0% | 13.9 | 58,645 | Common Stock |
Northern Oil and Gas Inc. | Michael D. Kelly | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 10,204 | 40,927 (0%) | 0% | 0 | Common Stock | |
Northern Oil and Gas Inc. | Michael D. Kelly | EVP of Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.76 per share. | 01 Jan 2021 | 876 | 30,723 (0%) | 0% | 8.8 | 7,674 | Common Stock |
Northern Oil and Gas Inc. | Michael D. Kelly | EVP of Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2020 | 16,073 | 31,599 (0%) | 0% | 0 | Common Stock | |
Mettler-Toledo Internation... | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2020 | 316 | 316 | - | - | Stock Option (right to buy) | |
Mettler-Toledo Internation... | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2020 | 41 | 1,557 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
Hookipa Pharma Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2020 | 5,754 | 5,754 (0%) | 0% | 0 | Common Stock | |
Aprea Therapeutics Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2020 | 12,000 | 12,000 | - | - | Stock Option (right to Buy) | |
Neogenomics Inc. | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2020 | 2,223 | 2,223 | - | - | Stock Option (Right to Buy) | |
Neogenomics Inc. | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2020 | 1,782 | 1,782 (0%) | 0% | 0 | Common Stock | |
DMC Global Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2020 | 2,055 | 2,055 (0%) | 0% | 0 | Common Stock | |
Hookipa Pharma Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 9,600 | 9,600 | - | - | Stock Option (Right to Buy) | |
Northern Oil and Gas Inc. | Michael D. Kelly | EVP of Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 105,263 | 155,263 (0%) | 0% | 0 | Common Stock | |
Cars.com | Michael Joseph Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2020 | 27,076 | 42,751 (0%) | 0% | 0 | Common Stock | |
Herc Holdings Inc | Michael A. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2020 | 4,819 | 14,218 (0%) | 0% | 0 | Common Stock |